Diffuse lung disease in young children: Application of a novel classification scheme

American Journal of Respiratory and Critical Care Medicine

Volumn 176, Issue 11, 2007, Pages 1120-1128

  Deutsch, Gail H ^a   Young, Lisa R ^a   Deterding, Robin R ^b   Fan, Leland L ^c   Dell, Sharon D ^d   Bean, Judy A ^a   Brody, Alan S ^a   Nogee, Lawrence M ^e   Trapnell, Bruce C ^a   Langston, Claire ^c   Albright, Eric A ^f   Askin, Frederic B ^e   Baker, Peter ^f   Chou, Pauline M ^g   Cool, Carlyne M ^h   Coventry, Susan C ⁱ   Cutz, Ernest ^d   Davis, Mary M ^j   Dishop, Megan K ^c   Galambos, Csaba ^k   Patterson, Kathleen ^l   Travis, William D ^m   Wert, Susan E ^a   White, Frances V ⁿ   more..

^a CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^b CHILDREN S HOSPITAL   (United States)

^c TEXAS CHILDREN S HOSPITAL   (United States)

^d HOSPITAL FOR SICK CHILDREN   (Canada)

^e JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f NATIONWIDE CHILDREN S HOSPITAL   (United States)

^g CHILDREN'S MEMORIAL HOSPITAL   (United States)

^h UNIVERSITY OF COLORADO   (United States)

ⁱ KOSAIR CHILDREN'S HOSPITAL   (United States)

^j RILEY HOSPITAL FOR CHILDREN   (United States)

^k CHILDREN S HOSPITAL OF PITTSBURGH   (United States)

^l SEATTLE CHILDREN S RESEARCH INSTITUTE   (United States)

^m MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

ⁿ WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

more..

Author keywords

Infant; Interstitial lung disease; Neuroendocrine hyperplasia; Pulmonary; Surfactant

Indexed keywords

ARTICLE; CELL HYPERPLASIA; CLINICAL FEATURE; COHORT ANALYSIS; DEVELOPMENTAL DISORDER; FIBROSING ALVEOLITIS; GENE MUTATION; GLYCOGEN STORAGE DISEASE; HUMAN; HUMAN TISSUE; INFANCY; INFANT; LUNG BIOPSY; LUNG DEVELOPMENT; MAJOR CLINICAL STUDY; MORTALITY; NEUROSECRETORY CELL; PRIORITY JOURNAL; PULMONARY HYPERTENSION;

ATP-BINDING CASSETTE TRANSPORTERS; COHORT STUDIES; ENDOCRINE SYSTEM DISEASES; GROWTH DISORDERS; HUMANS; HYPERTENSION, PULMONARY; INFANT; INFANT, NEWBORN; LUNG; LUNG DISEASES; MUTATION; NERVOUS SYSTEM DISEASES; PULMONARY SURFACTANTS; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; TERMINOLOGY AS TOPIC;

EID: 36849039441     PISSN: 1073449X     EISSN: 15354970     Source Type: Journal    
DOI: 10.1164/rccm.200703-393OC     Document Type: Article

References (42)

1. Fan LL, Deterding RR, Langston C. Pediatric interstitial lung disease revisited. Pediatr Pulmonol 2004;38:369-378.
2. Travis WD, King T, Bateman ED, Lynch DA, Capron F, Center M, Colby TV, Cordier J-F, duBois RM, Galvin JR, et al. ATS/ERS International multidisciplinary consensus classification of idiopathic interstitial pneumonia. Am J Respir Crit Care Med 2002;165:277-304.
3. Sharief N, Crawford OF, Dinwiddie R. Fibrosing alveolitis and desquamative interstitial pneumonitis. Pediatr Pulmonol 1994;17:359-365.
4. Nicholson AG, Kim H, Corrin B, Bush A, du Bois RM, Rosenthal M, Sheppard MN. The value of classifying interstitial pneumonitis in childhood according to defined histological patterns. Histopathology 1998;33:203-211.
5. Fan LL, Mullen AL, Brugman SM, Inscore SC, Parks DP, White CW. Clinical spectrum of chronic interstitial lung disease in children. J Pediatr 1992;121:867-872.
6. Fan LL, Langston C. Pediatric interstitial lung disease: children are not small adults. Am J Respir Crit Care Med 2002;165:1466-1467.
7. Fan LL, Kozinetz CA. Factors influencing survival in children with chronic interstitial lung disease. Am J Respir Crit Care Med 1997;156:939-942.
8. Tal A, Maor E, Bar-Ziv J, Gorodischer R. Fatal desquamative interstitial pneumonia in three infants siblings. J Pediatr 1984;104:873-876.
9. Shulenin S, Nogee LM, Annilo T, Wert SE, Whitsett JA, Dean M. ABCA3 gene mutations in newborns with fatal surfactant deficiency. N Engl J Med 2004;350:1296-1303.
10. Nogee LM, Dunbar AE III, Wert SE, Askin F, Hamvas A, Whitsett JA. A mutation in the surfactant protein C gene associated with familial interstitial lung disease. N Engl J Med 2001;344:573-579.
11. Bullard JE, Wert SE, Whitsett JA, Dean M, Nogee LM. ABCA3 mutations associated with pediatric interstitial lung disease. Am J Respir Crit Care Med 2005;172:1026-1031.
12. Fisher M, Roggli V, Merten D, Mulvihill D, Spock A. Coexisting endogenous lipoid pneumonia, cholesterol granulomas, and pulmonary alveolar proteinosis in a pediatric population: a clinical, radiographic, and pathologic correlation. Pediatr Pathol 1992;12:365-383.
13. Katzenstein AL, Gordon LP, Oliphant M, Swender PT. Chronic pneumonitis of infancy: a unique form of interstitial lung disease occurring in early childhood. Am J Surg Pathol 1995;19:439-447.
14. Kavantzas N, Theocharis S, Agapitos E, Davaris P. Chronic pneumonitis of infancy: an autopsy study of 12 cases. Clin Exp Pathol 1999;47:96-100.
15. Canakis AM, Cutz E, Manson D, O'Brodovich H. Pulmonary interstitial glycogenosis: a new variant of neonatal interstitial lung disease. Am J Respir Crit Care Med 2002;165:1557-1565.
16. Schroeder SA, Shannon DC, Mark EJ. Cellular interstitial pneumonitis in infants: a clinicopathologic study. Chest 1992;101:1065-1069.
17. Deterding RR, Pye C, Fan LL, Langston C. Persistent tachypnea of infancy is associated with neuroendocrine cell hyperplasia. Pediatr Pulmonol 2005;40:157-165.
18. Cameron HS, Somaschini M, Carrera P, Hamvas A, Whitsett JA, Wert SE, Deutsch G, Nogee LM. A common mutation in the surfactant protein C gene associated with lung disease. J Pediatr 2005;146:370-375.
19. Langston C. Pediatric lung biopsy, diagnostic pulmonary pathology. New York: Marcel Dekker, Inc.; 2000.
20. Langston C, Dishop MK. Infant lung biopsy: clarifying the pathologic spectrum. Pathol Int 2004;54:S414-S427.
21. Young LR, Deterding R, Deutsch GH, Hilman B, Dell S, Fan L, Langston C, and the pILD Pathology and Imaging Cooperative. Clinical characteristics of a new histologic classification of interstitial lung disease in infants [abstract]. Proc Am Thorac Soc 2005;2:A474.
22. Dishop MK, Deutsch GH, Deterding R, Fan LL, Young LR, Cutz E, Langston C, and the pILD Pathology and Imaging Cooperative. A working histologic classification of the pediatric interstitial lung disease cooperative group [abstract]. Proc Am Thorac Soc 2005;2:A474.
23. Dell SD, Young LR, Deterding R, Deutsch GH, Hilman B, Fan LL, Langston C. Lung biopsies and clinical characteristics of ILD in infants: Experience of 11 centers, 1999-2004 [abstract]. Proc Am Thorac Soc 2005;A475.
24. Deutsch GH, Albright E, Chou PM, Cool CD, Coventry S, Davis MM, Dishop MK, Galambos C, Patterson K, Wert SE, et al., for the pILD Pathology and Imaging Cooperative. Defining the spectrum of diffuse lung disease in infancy: a working classification of the Pediatric Interstitial Lung Disease Cooperative. Mod Pathol 2005;18:304.
25. Young LR, Deutsch GH, Long F, White F, Sweet S, Fan LL, Langston C, Deterding R, Brody A, and the Children's Interstitial Lung Disease Network. Growth abnormalities: an under-recognized cause of diffuse lung disease in young children [abstract]. Proc Am Thorac Soc 2006;3:A677.
26. Fan LL, Kozinetz CA, Deterding RR, Brugman SM. Evaluation of a diagnostic approach to pediatric interstitial lung disease. Pediatrics 1998;101:82-85.
27. Fan LL, Langston C. Chronic interstitial lung disease in children. Pediatr Pulmonol 1993;16:184-196.
28. Langston C, Fan LL. Diffuse interstitial lung disease in infants. Pediatr Pulmonol Suppl 2001;23:74-76.
29. Langston C, Fan LL. The spectrum of interstitial lung disease in childhood. Pediatr Pulmonol Suppl 2001;23:70-71.
30. Sherer DM, Davis JM, Woods JR Jr. Pulmonary hypoplasia: a review. Obstet Gynecol Surv 1990;45:792-803.
31. Cooney TP, Thurlbeck WM. Pulmonary hypoplasia in Down's syndrome. N Engl J Med 1982;307:1170-1173.
32. Johnson DE, Georgieff MK. Pulmonary neuroendocrine cells: their secretory products and their potential roles in health and chronic lung disease in infancy. Am Rev Respir Dis 1989;140:1807-1812.
33. Nogee LM, Dunbar AE III, Wert S, Askin F, Hamvas A, Whitsett JA. Mutations in the surfactant protein C gene associated with interstitial lung disease. Chest 2002;121:20S-21S.
34. Nogee LM, de Mello DE, Dehner LP, Colten HR. Brief report: deficiency of pulmonary surfactant protein B in congenital alveolar proteinosis. N Engl J Med 1993;328:406-410.
35. Chibbar R, Shih F, Baga M, Torlakovic E, Ramlall K, Skomro R, Cockcroft DW, Lemire EG. Nonspecific interstitial pneumonia and usual interstitial pneumonia with mutation in surfactant protein C in familial pulmonary fibrosis. Mod Pathol 2004;17:973-980.
36. Sondheimer HM, Lung MC, Brugman SM, Ikle DN, Fan LL, White CW. Pulmonary vascular disorders masquerading as interstitial lung disease. Pediatr Pulmonol 1995;20:284-288.
37. Dishop MK, Askin FB, Galambos C, White FV, Deterding RR, Young LR, Langston C, for the chILD Network. Classification of diffuse lung disease in older children and adolescents: a multi-institutional study of the Children's Interstitial Lung Disease (chILD) pathology working group. Mod Pathol 2007;20:287-288.
38. Clement A. Task force on chronic interstitial lung disease in immunocompetent children. Eur Respir J 2004;24:686-697.
39. Deterding R, Fan LL. Surfactant dysfunction mutations in children's interstitial lung disease and beyond. Am J Respir Crit Care Med 2005;172:940-941.
40. Langston C, Patterson K, Dishop MK, Askin F, Baker P, Chou P, Cool C, Coventry S, Cutz E, Davis M, et al. A protocol for the handling of tissue obtained by operative lung biopsy: recommendations of the chILD pathology co-operative group. Pediatr Dev Pathol 2006;9:173-180.
41. Husain AN, Siddiqui NH, Stocker JT. Pathology of arrested acinar development in postsurfactant bronchopulmonary dysplasia. Hum Pathol 1998;29:710-717.
42. Davies SJ, Gosney JR, Hansell DM, Wells AU, du Bois RM, Burke MM, Sheppard MN, Nicholson AG. Diffuse idiopathic pulmonary neuroendocrine cell hyperplasia: an under-recognised spectrum of disease. Thorax 2007;62:248-252.